Emmanuel J Favaloro/LinkedIn
Jan 9, 2026, 07:19
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of a bleeding disorder “pseudo-hemophilia’ that was later to become known as von Willebrand disease.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the first one in queue – on type 2A VWD.
Enjoy!”
Read the full article here.
Article: Von Willebrand Disease Type 2A: An Update
Authors: Omid Seidizadeh , Luciano Baronciani , Pier Mannuccio Mannucci , Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients